nodes	percent_of_prediction	percent_of_DWPC	metapath
Methyldopa—COMT—autistic disorder	0.749	1	CbGaD
Methyldopa—DDC—telencephalic ventricle—autistic disorder	0.0144	0.192	CbGeAlD
Methyldopa—COMT—telencephalic ventricle—autistic disorder	0.00952	0.127	CbGeAlD
Methyldopa—DDC—hindbrain—autistic disorder	0.00679	0.0904	CbGeAlD
Methyldopa—DDC—brainstem—autistic disorder	0.00389	0.0518	CbGeAlD
Methyldopa—DDC—forebrain—autistic disorder	0.00376	0.05	CbGeAlD
Methyldopa—DDC—telencephalon—autistic disorder	0.00346	0.046	CbGeAlD
Methyldopa—COMT—brainstem—autistic disorder	0.00258	0.0343	CbGeAlD
Methyldopa—COMT—eye—autistic disorder	0.00251	0.0334	CbGeAlD
Methyldopa—COMT—forebrain—autistic disorder	0.00249	0.0331	CbGeAlD
Methyldopa—COMT—telencephalon—autistic disorder	0.00229	0.0304	CbGeAlD
Methyldopa—DDC—head—autistic disorder	0.00215	0.0286	CbGeAlD
Methyldopa—DDC—nervous system—autistic disorder	0.00204	0.0272	CbGeAlD
Methyldopa—DDC—central nervous system—autistic disorder	0.00196	0.0261	CbGeAlD
Methyldopa—SLC15A1—digestive system—autistic disorder	0.00196	0.0261	CbGeAlD
Methyldopa—COMT—digestive system—autistic disorder	0.00174	0.0232	CbGeAlD
Methyldopa—DDC—brain—autistic disorder	0.00156	0.0208	CbGeAlD
Methyldopa—COMT—head—autistic disorder	0.00142	0.0189	CbGeAlD
Methyldopa—COMT—nervous system—autistic disorder	0.00135	0.018	CbGeAlD
Methyldopa—COMT—central nervous system—autistic disorder	0.0013	0.0173	CbGeAlD
Methyldopa—COMT—cerebellum—autistic disorder	0.00127	0.0169	CbGeAlD
Methyldopa—ADRA2A—forebrain—autistic disorder	0.00127	0.0168	CbGeAlD
Methyldopa—ADRA2A—telencephalon—autistic disorder	0.00116	0.0155	CbGeAlD
Methyldopa—Isoprenaline—MAPK1—autistic disorder	0.00115	0.181	CrCbGaD
Methyldopa—COMT—brain—autistic disorder	0.00103	0.0137	CbGeAlD
Methyldopa—ADRA2A—head—autistic disorder	0.000725	0.00964	CbGeAlD
Methyldopa—Isoetarine—ADRB2—autistic disorder	0.000696	0.11	CrCbGaD
Methyldopa—ADRA2A—nervous system—autistic disorder	0.000687	0.00914	CbGeAlD
Methyldopa—ADRA2A—central nervous system—autistic disorder	0.000662	0.0088	CbGeAlD
Methyldopa—ADRA2A—cerebellum—autistic disorder	0.000647	0.0086	CbGeAlD
Methyldopa—ADRA2A—brain—autistic disorder	0.000525	0.00699	CbGeAlD
Methyldopa—Dopamine—MAOB—autistic disorder	0.0005	0.0786	CrCbGaD
Methyldopa—Dopamine—COMT—autistic disorder	0.000465	0.0731	CrCbGaD
Methyldopa—Dopamine—MAOA—autistic disorder	0.00035	0.0551	CrCbGaD
Methyldopa—L-DOPA—DRD3—autistic disorder	0.000349	0.0549	CrCbGaD
Methyldopa—L-DOPA—DRD1—autistic disorder	0.000343	0.0539	CrCbGaD
Methyldopa—Dopamine—DRD3—autistic disorder	0.000325	0.0511	CrCbGaD
Methyldopa—Dopamine—DRD1—autistic disorder	0.000319	0.0501	CrCbGaD
Methyldopa—Droxidopa—ADRB2—autistic disorder	0.000318	0.05	CrCbGaD
Methyldopa—Isoprenaline—ADRB2—autistic disorder	0.000289	0.0455	CrCbGaD
Methyldopa—Aminosalicylic Acid—PTGS2—autistic disorder	0.000288	0.0453	CrCbGaD
Methyldopa—Norepinephrine—ADRB2—autistic disorder	0.000268	0.0421	CrCbGaD
Methyldopa—Epinephrine—ADRB2—autistic disorder	0.000243	0.0382	CrCbGaD
Methyldopa—Mesalazine—PTGS2—autistic disorder	0.000226	0.0356	CrCbGaD
Methyldopa—Dopamine—SLC6A4—autistic disorder	0.000226	0.0355	CrCbGaD
Methyldopa—DDC—Metabolism—RORA—autistic disorder	7.4e-05	0.000438	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AVPR1A—autistic disorder	7.29e-05	0.000431	CbGpPWpGaD
Methyldopa—COMT—Metabolism—ADA—autistic disorder	7.21e-05	0.000426	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR1B—autistic disorder	7.09e-05	0.000419	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—OXT—autistic disorder	7.09e-05	0.000419	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GRM5—autistic disorder	7.04e-05	0.000416	CbGpPWpGaD
Methyldopa—DDC—SIDS Susceptibility Pathways—IL6—autistic disorder	6.94e-05	0.00041	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOB—autistic disorder	6.94e-05	0.00041	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—INPP1—autistic disorder	6.9e-05	0.000408	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ACADSB—autistic disorder	6.9e-05	0.000408	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OXTR—autistic disorder	6.82e-05	0.000403	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—SCT—autistic disorder	6.75e-05	0.000399	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR5A—autistic disorder	6.64e-05	0.000393	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—KCNMA1—autistic disorder	6.6e-05	0.00039	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD1—autistic disorder	6.59e-05	0.000389	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—MAPK1—autistic disorder	6.57e-05	0.000388	CbGpPWpGaD
Methyldopa—COMT—Metabolism—RORA—autistic disorder	6.57e-05	0.000388	CbGpPWpGaD
Methyldopa—DDC—Metabolism—TPH2—autistic disorder	6.45e-05	0.000381	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADM—autistic disorder	6.44e-05	0.000381	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—GABBR1—autistic disorder	6.44e-05	0.000381	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF2—autistic disorder	6.39e-05	0.000378	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—DRD3—autistic disorder	6.38e-05	0.000377	CbGpPWpGaD
Methyldopa—DDC—Metabolism—DPYD—autistic disorder	6.34e-05	0.000375	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOB—autistic disorder	6.16e-05	0.000364	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—BTD—autistic disorder	6.15e-05	0.000363	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OPRM1—autistic disorder	6.08e-05	0.000359	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—ADRB2—autistic disorder	6.03e-05	0.000357	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PLA2G4A—autistic disorder	6.03e-05	0.000357	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR5A—autistic disorder	6.03e-05	0.000357	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CACNA1C—autistic disorder	5.9e-05	0.000349	CbGpPWpGaD
Methyldopa—SLC15A1—Transmembrane transport of small molecules—AVP—autistic disorder	5.86e-05	0.000346	CbGpPWpGaD
Methyldopa—COMT—Metabolism—TPH2—autistic disorder	5.73e-05	0.000338	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—ITGB3—autistic disorder	5.72e-05	0.000338	CbGpPWpGaD
Methyldopa—DDC—Circadian rythm related genes—IL6—autistic disorder	5.67e-05	0.000335	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GABBR2—autistic disorder	5.65e-05	0.000334	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DPYD—autistic disorder	5.63e-05	0.000333	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR1B—autistic disorder	5.4e-05	0.000319	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—OXT—autistic disorder	5.4e-05	0.000319	CbGpPWpGaD
Methyldopa—DDC—Metabolism—DHFR—autistic disorder	5.37e-05	0.000317	CbGpPWpGaD
Methyldopa—COMT—Transmission across Chemical Synapses—HRAS—autistic disorder	5.28e-05	0.000312	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CACNA1C—autistic disorder	5.24e-05	0.00031	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TDO2—autistic disorder	5.23e-05	0.000309	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—autistic disorder	5.17e-05	0.000306	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GABBR2—autistic disorder	5.13e-05	0.000303	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—MAPK1—autistic disorder	5.04e-05	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1D—autistic disorder	5.03e-05	0.000298	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD1—autistic disorder	5.02e-05	0.000297	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DHCR7—autistic disorder	4.92e-05	0.000291	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—DRD3—autistic disorder	4.86e-05	0.000287	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AVP—autistic disorder	4.86e-05	0.000287	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—TF—autistic disorder	4.77e-05	0.000282	CbGpPWpGaD
Methyldopa—COMT—Metabolism—DHFR—autistic disorder	4.76e-05	0.000282	CbGpPWpGaD
Methyldopa—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—autistic disorder	4.72e-05	0.000279	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—CALCA—autistic disorder	4.7e-05	0.000278	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PRKCB—autistic disorder	4.68e-05	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GRM8—autistic disorder	4.68e-05	0.000277	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—EXT1—autistic disorder	4.66e-05	0.000275	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC6A8—autistic disorder	4.66e-05	0.000275	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1D—autistic disorder	4.57e-05	0.00027	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—PIK3CG—autistic disorder	4.48e-05	0.000265	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DAO—autistic disorder	4.45e-05	0.000263	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—EGF—autistic disorder	4.43e-05	0.000262	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4A—autistic disorder	4.4e-05	0.00026	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—UPB1—autistic disorder	4.26e-05	0.000252	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL5—autistic disorder	4.25e-05	0.000251	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GRM8—autistic disorder	4.25e-05	0.000251	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CYP19A1—autistic disorder	4.2e-05	0.000248	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AVPR1A—autistic disorder	4.12e-05	0.000244	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—WNT2—autistic disorder	4.12e-05	0.000243	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IGF1—autistic disorder	4.1e-05	0.000242	CbGpPWpGaD
Methyldopa—ADRA2A—G alpha (i) signalling events—POMC—autistic disorder	4.06e-05	0.00024	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITGA4—autistic disorder	4.06e-05	0.00024	CbGpPWpGaD
Methyldopa—COMT—Neuronal System—HRAS—autistic disorder	4.04e-05	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—autistic disorder	4.04e-05	0.000239	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4A—autistic disorder	4e-05	0.000236	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—VIP—autistic disorder	3.98e-05	0.000235	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GRM5—autistic disorder	3.98e-05	0.000235	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM5—autistic disorder	3.96e-05	0.000234	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ASMT—autistic disorder	3.96e-05	0.000234	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—ADRB2—autistic disorder	3.94e-05	0.000233	CbGpPWpGaD
Methyldopa—DDC—Metabolism—COMT—autistic disorder	3.91e-05	0.000231	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—autistic disorder	3.9e-05	0.00023	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTP1—autistic disorder	3.89e-05	0.00023	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MAOA—autistic disorder	3.88e-05	0.000229	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OXTR—autistic disorder	3.85e-05	0.000228	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—SCT—autistic disorder	3.82e-05	0.000226	CbGpPWpGaD
Methyldopa—DDC—Metabolism—CAT—autistic disorder	3.78e-05	0.000224	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AVPR1A—autistic disorder	3.74e-05	0.000221	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CYP19A1—autistic disorder	3.73e-05	0.000221	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC25A12—autistic disorder	3.72e-05	0.00022	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NRP2—autistic disorder	3.72e-05	0.00022	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLAUR—autistic disorder	3.7e-05	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—AVP—autistic disorder	3.7e-05	0.000219	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—GABBR1—autistic disorder	3.64e-05	0.000215	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADM—autistic disorder	3.64e-05	0.000215	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—SLC19A1—autistic disorder	3.62e-05	0.000214	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GRM5—autistic disorder	3.61e-05	0.000214	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—VIP—autistic disorder	3.61e-05	0.000214	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PLA2G4A—autistic disorder	3.57e-05	0.000211	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GSTM1—autistic disorder	3.57e-05	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR5A—autistic disorder	3.56e-05	0.000211	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PDE4B—autistic disorder	3.55e-05	0.00021	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OXTR—autistic disorder	3.5e-05	0.000207	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—SCT—autistic disorder	3.46e-05	0.000205	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTP1—autistic disorder	3.45e-05	0.000204	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MAOA—autistic disorder	3.44e-05	0.000204	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OPRM1—autistic disorder	3.44e-05	0.000203	CbGpPWpGaD
Methyldopa—DDC—Metabolism—GPX1—autistic disorder	3.42e-05	0.000202	CbGpPWpGaD
Methyldopa—COMT—Metabolism—CAT—autistic disorder	3.36e-05	0.000199	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—GABBR1—autistic disorder	3.31e-05	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADM—autistic disorder	3.31e-05	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF2—autistic disorder	3.29e-05	0.000195	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADSL—autistic disorder	3.23e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Class A/1 (Rhodopsin-like receptors)—POMC—autistic disorder	3.23e-05	0.000191	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PDE4B—autistic disorder	3.22e-05	0.00019	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GSTM1—autistic disorder	3.17e-05	0.000188	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PLA2G4A—autistic disorder	3.17e-05	0.000188	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—XDH—autistic disorder	3.17e-05	0.000187	CbGpPWpGaD
Methyldopa—DDC—Metabolism—MTHFR—autistic disorder	3.16e-05	0.000187	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—IL2—autistic disorder	3.15e-05	0.000186	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OPRM1—autistic disorder	3.12e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PLA2G4A—autistic disorder	3.11e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—STX1A—autistic disorder	3.11e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—NPAS2—autistic disorder	3.11e-05	0.000184	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—HTR2A—autistic disorder	3.08e-05	0.000182	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—OXT—autistic disorder	3.05e-05	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR1B—autistic disorder	3.05e-05	0.00018	CbGpPWpGaD
Methyldopa—COMT—Metabolism—GPX1—autistic disorder	3.04e-05	0.00018	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GABBR2—autistic disorder	3.03e-05	0.000179	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TCN2—autistic disorder	3e-05	0.000177	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—ITGB3—autistic disorder	2.95e-05	0.000174	CbGpPWpGaD
Methyldopa—DDC—Metabolism—APOE—autistic disorder	2.94e-05	0.000174	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—ADA—autistic disorder	2.86e-05	0.000169	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD1—autistic disorder	2.84e-05	0.000168	CbGpPWpGaD
Methyldopa—COMT—Metabolism—MTHFR—autistic disorder	2.8e-05	0.000166	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—OXT—autistic disorder	2.77e-05	0.000164	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR1B—autistic disorder	2.77e-05	0.000164	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—DRD3—autistic disorder	2.75e-05	0.000162	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1D—autistic disorder	2.7e-05	0.00016	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL5—autistic disorder	2.69e-05	0.000159	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—CALCA—autistic disorder	2.66e-05	0.000157	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PIK3CG—autistic disorder	2.65e-05	0.000157	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—RORA—autistic disorder	2.61e-05	0.000154	CbGpPWpGaD
Methyldopa—COMT—Metabolism—APOE—autistic disorder	2.61e-05	0.000154	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRLR—autistic disorder	2.6e-05	0.000154	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD1—autistic disorder	2.57e-05	0.000152	CbGpPWpGaD
Methyldopa—DDC—Metabolism—POMC—autistic disorder	2.53e-05	0.000149	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GRM8—autistic disorder	2.51e-05	0.000148	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—DRD3—autistic disorder	2.49e-05	0.000147	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR ligand binding—POMC—autistic disorder	2.46e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOB—autistic disorder	2.45e-05	0.000145	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL5—autistic disorder	2.44e-05	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—WNT2—autistic disorder	2.43e-05	0.000144	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PRKCB—autistic disorder	2.41e-05	0.000143	CbGpPWpGaD
Methyldopa—ADRA2A—Platelet activation, signaling and aggregation—MAPK1—autistic disorder	2.41e-05	0.000143	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—CALCA—autistic disorder	2.41e-05	0.000143	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GHR—autistic disorder	2.4e-05	0.000142	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—NOS2—autistic disorder	2.38e-05	0.000141	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4A—autistic disorder	2.36e-05	0.00014	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PIK3CG—autistic disorder	2.36e-05	0.000139	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—PIK3CG—autistic disorder	2.31e-05	0.000136	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—EGF—autistic disorder	2.28e-05	0.000135	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—TPH2—autistic disorder	2.28e-05	0.000134	CbGpPWpGaD
Methyldopa—COMT—Metabolism—POMC—autistic disorder	2.24e-05	0.000133	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DPYD—autistic disorder	2.24e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—ADRB2—autistic disorder	2.22e-05	0.000132	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AVPR1A—autistic disorder	2.21e-05	0.000131	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GRM5—autistic disorder	2.13e-05	0.000126	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—VIP—autistic disorder	2.13e-05	0.000126	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IGF1—autistic disorder	2.11e-05	0.000125	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—AVP—autistic disorder	2.09e-05	0.000124	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CACNA1C—autistic disorder	2.08e-05	0.000123	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OXTR—autistic disorder	2.07e-05	0.000122	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SCT—autistic disorder	2.05e-05	0.000121	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—ADRB2—autistic disorder	2.02e-05	0.000119	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTGS2—autistic disorder	2.01e-05	0.000119	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—SERPINE1—autistic disorder	2.01e-05	0.000119	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GABBR1—autistic disorder	1.95e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADM—autistic disorder	1.95e-05	0.000115	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EIF4E—autistic disorder	1.92e-05	0.000113	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PDE4B—autistic disorder	1.9e-05	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—AVP—autistic disorder	1.9e-05	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—DHFR—autistic disorder	1.89e-05	0.000112	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OPRM1—autistic disorder	1.84e-05	0.000109	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTGS2—autistic disorder	1.79e-05	0.000106	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PLA2G4A—autistic disorder	1.78e-05	0.000105	CbGpPWpGaD
Methyldopa—DDC—Metabolism—PTEN—autistic disorder	1.76e-05	0.000104	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—HTR2A—autistic disorder	1.74e-05	0.000103	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—GZMB—autistic disorder	1.69e-05	9.96e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR1B—autistic disorder	1.64e-05	9.67e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—OXT—autistic disorder	1.64e-05	9.67e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—IL2—autistic disorder	1.63e-05	9.61e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HTR2A—autistic disorder	1.58e-05	9.34e-05	CbGpPWpGaD
Methyldopa—COMT—Metabolism—PTEN—autistic disorder	1.56e-05	9.22e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PRKCB—autistic disorder	1.52e-05	9.01e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD1—autistic disorder	1.52e-05	8.99e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TSC1—autistic disorder	1.52e-05	8.99e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CYP19A1—autistic disorder	1.48e-05	8.77e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—NTRK2—autistic disorder	1.48e-05	8.75e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—DRD3—autistic disorder	1.47e-05	8.71e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—PIK3CG—autistic disorder	1.46e-05	8.63e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL5—autistic disorder	1.44e-05	8.52e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—CALCA—autistic disorder	1.42e-05	8.42e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—POMC—autistic disorder	1.39e-05	8.21e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PRKCB—autistic disorder	1.38e-05	8.19e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—COMT—autistic disorder	1.38e-05	8.15e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTP1—autistic disorder	1.37e-05	8.11e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MAOA—autistic disorder	1.37e-05	8.09e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—CAT—autistic disorder	1.34e-05	7.89e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—PIK3CG—autistic disorder	1.33e-05	7.83e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—POMC—autistic disorder	1.26e-05	7.46e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PLA2G4A—autistic disorder	1.26e-05	7.45e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GSTM1—autistic disorder	1.26e-05	7.45e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRL—autistic disorder	1.26e-05	7.44e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—MAPK1—autistic disorder	1.24e-05	7.35e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—GPX1—autistic disorder	1.21e-05	7.14e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ADRB2—autistic disorder	1.19e-05	7.06e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—AVP—autistic disorder	1.12e-05	6.63e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF2—autistic disorder	1.12e-05	6.6e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—MTHFR—autistic disorder	1.11e-05	6.59e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PLA2G4A—autistic disorder	1.05e-05	6.23e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—APOE—autistic disorder	1.04e-05	6.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—GPCR downstream signaling—IL2—autistic disorder	1.03e-05	6.07e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MEF2C—autistic disorder	1.03e-05	6.06e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—ITGB3—autistic disorder	9.99e-06	5.91e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Hemostasis—HRAS—autistic disorder	9.98e-06	5.9e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PIK3CG—autistic disorder	9.36e-06	5.53e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HTR2A—autistic disorder	9.33e-06	5.52e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL2—autistic disorder	9.33e-06	5.51e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—POMC—autistic disorder	8.91e-06	5.27e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—TSC2—autistic disorder	8.86e-06	5.24e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—LEP—autistic disorder	8.67e-06	5.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APOE—autistic disorder	8.67e-06	5.13e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PRKCB—autistic disorder	8.18e-06	4.84e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—APC—autistic disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PIK3CG—autistic disorder	7.83e-06	4.63e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—EGF—autistic disorder	7.74e-06	4.57e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—POMC—autistic disorder	7.45e-06	4.4e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IGF1—autistic disorder	7.17e-06	4.24e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—MAPK1—autistic disorder	7.13e-06	4.22e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTGS2—autistic disorder	7.11e-06	4.2e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—SERPINE1—autistic disorder	6.81e-06	4.02e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Metabolism—PTEN—autistic disorder	6.2e-06	3.66e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—HRAS—autistic disorder	5.73e-06	3.39e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL2—autistic disorder	5.51e-06	3.26e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling by GPCR—IL6—autistic disorder	5.48e-06	3.24e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—PTEN—autistic disorder	5.18e-06	3.06e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—MAPK1—autistic disorder	4.21e-06	2.49e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—HRAS—autistic disorder	3.38e-06	2e-05	CbGpPWpGaD
Methyldopa—ADRA2A—Signaling Pathways—IL6—autistic disorder	3.24e-06	1.91e-05	CbGpPWpGaD
